IDNA ETF (iShares Genomics Immunology and Healthcare ETF) is managed by iShares by BlackRock (US) with $153.7M in net assets. IDNA expense ratio is 0.47%, holding 64 positions across sectors including Health Care, Unknown, Other. Inception date: 2019-06-11.

IDNA performance shows a YTD return of 18.32%. The 1-year return is 37.97% and the 5-year return is -7.33%. IDNA dividend yield stands at 0.99%, paid semi-annually.

IDNA top holdings include Moderna therapeutics (5.7%), Bayer Ag (5.0%), Takeda Pharmaceutical Co Ltd (4.5%), Revolution Medicines Inc Ser C Pc Pp (4.4%), Developed Markets Roche Holding Ag (participation Certificate) (4.4%). View all IDNA holdings, sector breakdown, or dividend history.

IDNA can be compared against other funds using the overlap calculator or side-by-side comparison tool. IDNA alternatives are available via the screener, along with tax-loss harvesting opportunities.